ADC Therapeutics SA Quarterly Earnings Per Share, Basic in USD/shares from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
ADC Therapeutics SA quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2023 to Q2 2024.
  • ADC Therapeutics SA Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.38 USD/shares, a 36.7% increase year-over-year.
  • ADC Therapeutics SA annual Earnings Per Share, Basic for 2023 was -2.94 USD/shares, a 46.3% decline from 2022.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 +$0.22 +36.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$1 +$0.17 +23.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q2 2023 -$1 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$1 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.